The largest database of trusted experimental protocols

6 protocols using gsk3787

1

Antagonizing PPAR-δ in 4T1 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 4T1 cells (ATCC) were incubated with RPMI-1640 medium (Gibco, Carlsbad, CA) containing 10% fetal bovine serum in an incubator at 37 °C and 5% CO2. The PPAR-δ in 4T1 cells was antagonized using different concentrations (1, 5, 10, 20, 40 or 80 µM) of the PPAR-δ antagonist GSK3787 (S8025, Selleck). Total protein extracts were obtained using a total protein extraction kit (KeyGEN Biotech, Jiangsu, China) according to the manufacturer's instructions. Protein concentrations were measured using a BCA protein assay (23227, Thermo Fisher Scientific) according to the manufacturers' protocols to ensure equal protein loading for each sample.
+ Open protocol
+ Expand
2

HUVEC Culture and Treatment Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human umbilical vein endothelial cells (HUVEC) were purchased from PromoCell (Heidelberg, Germany) and grown in endothelial cell growth medium (PromoCell) supplemented with gentamycin (50 µg mL−1) and amphotericin B (50 ng mL−1). For all experiments, we used HUVECs pooled from up to four donors, which did not exceed passage 4. Human embryonic kidney (HEK) 293 cells (ATCC CRL-1573) were grown in DMEM medium (Invitrogen, Cergy Pontoise, France) supplemented with 10% fetal calf serum (FCS), 100 IU mL−1 penicillin, and 100 µg mL−1 streptomycin (Invitrogen, Cergy Pontoise, France). C166 mouse endothelial cells (accession number CRL-2581) and LLC1 mouse lung cancer cells (accession number CRL-1642) were grown in DMEM medium (Invitrogen, Cergy Pontoise, France). Media were supplemented with 10% fetal calf serum (FCS), 100 IU mL−1 penicillin and 100 µg mL−1 streptomycin. As positive control for apoptosis assays, LLC1 mouse lung cancer cells were treated with 100 nmol/L Staurosporine (Sigma, St. Louis, MO, USA) overnight. For RNA isolation and quantitative RT-PCR experiments, HUVEC and LLC1 cells were maintained for 48 h (HUVEC) or 24 h (LLC1) in medium in the presence of GW0742 (Selleckchem, Houston, TX, USA) or GSK3787 (Selleckchem) dissolved in dimethyl sulfoxide (DMSO) at concentrations of 1 µmol/L. Controls were treated with vehicle (0.1% DMSO) only [6 (link),16 (link)].
+ Open protocol
+ Expand
3

Chondrocyte Differentiation and Apoptosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant rat IL-1β (Peprotech), PPARδ (abcam, ab23673), Aggrecan (abcam, ab3773), Collagen II (abcam, ab239007), MMP13 (abcam, ab39012), SOX9 (abcam, ab185966), Cleaved-PARP (Cell Signaling Technology, Asp214), Cleaved-caspase3 (Cell Signaling Technology, Asp175), Bcl-2 (abcam, ab194583), Bax (Cell Signaling Technology D2E11), ATG5 (abcam, ab108327), Beclin1 (abcam, ab62557), LC3 (Sigma-Aldrich, L8918), GW501516 (Selleck, S5616), GSK3787 (Selleck, S8025).
+ Open protocol
+ Expand
4

Investigating LPA-induced signaling in BMDCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
BMDCs were independently pretreated for 1 hour with the p38 MAPK inhibitor SB203580 (10 μM; Invivogen Cat# tlrl-sb20), the PPAR alpha antagonist GW6471 (50 μM; Selleck Chemical Cat# S2798), the PPAR delta antagonist GSK3787 (10 μM; Selleck Chemical Cat# S8025), the CREB inhibitor 666–15 (10 μM; MedChem Express, Cat# HY-128686); the JNK inhibitor JNK-IN-8 (10 μM; Selleck Chemical Cat# S4901); the NF-κB inhibitor BAY 11–7821 (50 μM; MedChem Express Cat# HY-13453), or the NF-κB/AP1 dual inhibitor SP 100030 (5 μM; Tocris Cat# 5309) and then stimulated with LPA (100 μM) for 2 hours. Expression of Ptgs2 was determined by RT-qPCR. For in vitro assessment of EP4 signaling, BMDCs were pretreated for 1 hour with the EP4 antagonist PGN 1531 (5 μM; Tocris Cat#5327) and then stimulated with LPA (100 μM) and LPS (100 ng/ml) for 4 hours. Expression of type-I ISGs was subsequently quantified by RT-qPCR.
+ Open protocol
+ Expand
5

Phosphatase Inhibitor Library Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Phosphotase Inhibitor Library was obtained from the National Compound Resource Center (NCRC, Shanghai). Other reagents were obtained as indicated: BML-260 (Life Chemicals, F0207-0150), ISO (Sigma, I6379), CL316243 disodium salt (Tocris, 1499), GW9662 (Selleck, S2915), T0070907(Selleck, S2871), GSK3787(Selleck, S8025), insulin (Sigma, I3536), T3 (Sigma, T2877), indomethacin (Sigma, I7378), dexamethasone (Sigma, D4902), isobutylmethylxanthine (Sigma, I5879), and rosiglitazone (Santa Cruz, sc202795).
+ Open protocol
+ Expand
6

Modulation of Brain Endothelial Cell Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
The confluent hBMECs monolayer in 6-cm dishes (Corning, NY, USA) were infected by PCN033 at MOI of 10 for 0 h, 1 h, 2 h, and 3 h. In some assays, cells were pretreated with the PPARβ/δ inhibitor GSK3787 (Selleck Chemicals, Houston, TX, USA), PPARγ inhibitor T0070907 (Selleck Chemicals), or RhoA inhibitor CCG1423 (Selleck Chemicals) for 3 hours prior to the infection, or incubated with 100 ng human rANGPTL4 protein (R&D Systems, Minneapolis, MN, USA) for 24 h. Cells were then collected for total RNA extraction and cDNA transcription. The expression of ANGPTL4, PPARβ/δ, PPARγ, EGR-1, E-selectin, ICAM-1, VEGFA, MYL5, ARHGAP5, and RhoA were determined by qPCR with primers listed in Table S2. GAPDH was used as the reference control. Each qPCR assay was performed in triplicates. Total protein expression of ZO-1, Claudin5, Occludin, ARHGAP5, and RhoA was determined by Western Blotting. GAPDH or β-actin was detected as the loading control.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!